Skip to main navigation
Skip to search
Skip to main content
Fujita Health University Home
English
日本語
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Escherichia coli sequence type 131: Epidemiology and challenges in treatment
Zubair A. Qureshi,
Yohei Doi
Research output
:
Contribution to journal
›
Review article
›
peer-review
16
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Escherichia coli sequence type 131: Epidemiology and challenges in treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Quinolone Derivative
100%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
100%
Cystitis
100%
Fosfomycin
50%
Trimethoprim/Sulfamethoxazole
50%
Intestine Infection
50%
Pivmecillinam
50%
Keyphrases
Pivmecillinam
62%
CTX-M ESBLs
62%
Uncomplicated Cystitis
62%
Global Epidemic
62%
Extraintestinal Infection
62%
Local Epidemiology
62%
Epidemiological Risk
62%
Oral Agents
62%
Pharmacology, Toxicology and Pharmaceutical Science
Extended Spectrum Beta Lactamase Producing Escherichia Coli
100%
Cystitis
100%
Pivmecillinam
50%
Intestine Infection
50%